Literature DB >> 12460190

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division.

Geon Kook Lee1, Hyeon Jin Park, Megan Macleod, Phillip Chandler, David H Munn, Andrew L Mellor.   

Abstract

Cells expressing indoleamine 2,3-dioxygenase (IDO), an enzyme which catabolizes tryptophan, prevent T-cell proliferation in vitro, suppress maternal antifetal immunity during pregnancy and inhibit T-cell-mediated responses to tumour-associated antigens. To examine the mechanistic basis of these phenomena we activated naïve murine T cells in chemically defined tryptophan-free media. Under these conditions T cells expressed CD25 and CD69 and progressed through the first 12 hr of G0/G1 phase but did not express CD71, cyclin D3, cdk4, begin DNA synthesis, or differentiate into cytotoxic effector cells. In addition, activated T cells with their growth arrested by tryptophan deprivation exhibited enhanced tendencies to die via apoptosis when exposed to anti-Fas antibodies. Apoptosis was inhibited by caspase inhibitor and was not observed when T cells originated from Fas-deficient mice. These findings suggest that T cells activated in the absence of free tryptophan entered the cell cycle but cell cycle progression ceased in mid-G1 phase and T cells became susceptible to death via apoptosis, in part though Fas-mediated signalling. Thus, mature antigen-presenting cells expressing IDO and Fas-ligand may induce antigen-specific T-cell tolerance by blocking T-cell cycle progression and by rapid induction of T-cell activation induced cell death in local tissue microenvironments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460190      PMCID: PMC1782830          DOI: 10.1046/j.1365-2567.2002.01526.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells.

Authors:  U Grohmann; F Fallarino; S Silla; R Bianchi; M L Belladonna; Carmine Vacca; A Micheletti; M C Fioretti; P Puccetti
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

Review 2.  Dendritic cells and prospects for transplantation tolerance.

Authors:  P J Fairchild; H Waldmann
Journal:  Curr Opin Immunol       Date:  2000-10       Impact factor: 7.486

Review 3.  The role of T cell apoptosis in transplantation tolerance.

Authors:  X C Li; A D Wells; T B Strom; L A Turka
Journal:  Curr Opin Immunol       Date:  2000-10       Impact factor: 7.486

4.  Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells.

Authors:  Francesca Fallarino; Carmine Vacca; Ciriana Orabona; Maria L Belladonna; Roberta Bianchi; Brendan Marshall; Derin B Keskin; Andrew L Mellor; Maria C Fioretti; Ursula Grohmann; Paolo Puccetti
Journal:  Int Immunol       Date:  2002-01       Impact factor: 4.823

5.  Functional characterization of Jurkat T cells rescued from CD95/Fas-induced apoptosis through the inhibition of caspases.

Authors:  S C Ko; V L Johnson; S C Chow
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

Review 6.  Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

Authors:  A L Mellor; D H Munn
Journal:  Immunol Today       Date:  1999-10

7.  Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Authors:  A L Mellor; J Sivakumar; P Chandler; K Smith; H Molina; D Mao; D H Munn
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

8.  Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.

Authors:  Angela M Alexander; Megan Crawford; Suzanne Bertera; William A Rudert; Osamu Takikawa; Paul D Robbins; Massimo Trucco
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

9.  Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.

Authors:  P Hwu; M X Du; R Lapointe; M Do; M W Taylor; H A Young
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

10.  Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

Authors:  Andrew L Mellor; Derin B Keskin; Theodore Johnson; Phillip Chandler; David H Munn
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

View more
  125 in total

Review 1.  New frontiers in primary immunodeficiency disorders: immunology and beyond….

Authors:  Eleonora Gambineri
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

2.  Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.

Authors:  Rikke Baek Sørensen; Sine Reker Hadrup; Inge Marie Svane; Mads Christian Hjortsø; Per Thor Straten; Mads Hald Andersen
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

Review 3.  A guide to immunometabolism for immunologists.

Authors:  Luke A J O'Neill; Rigel J Kishton; Jeff Rathmell
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

4.  Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.

Authors:  Min-Hee Oh; Im-Hong Sun; Liang Zhao; Robert D Leone; Im-Meng Sun; Wei Xu; Samuel L Collins; Ada J Tam; Richard L Blosser; Chirag H Patel; Judson M Englert; Matthew L Arwood; Jiayu Wen; Yee Chan-Li; Lukáš Tenora; Pavel Majer; Rana Rais; Barbara S Slusher; Maureen R Horton; Jonathan D Powell
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 5.  Failed central nervous system regeneration: a downside of immune privilege?

Authors:  Ingo Bechmann
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

Authors:  Ursula Hainz; Petra Obexer; Christiana Winkler; Peter Sedlmayr; Osamu Takikawa; Hildegard Greinix; Anita Lawitschka; Ulrike Pötschger; Dietmar Fuchs; Stephan Ladisch; Andreas Heitger
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

7.  Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Authors:  Esther Larrea; José I Riezu-Boj; Lucía Gil-Guerrero; Noelia Casares; Rafael Aldabe; Pablo Sarobe; María P Civeira; Jonathan L Heeney; Christine Rollier; Babs Verstrepen; Takaji Wakita; Francisco Borrás-Cuesta; Juan J Lasarte; Jesús Prieto
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 8.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

9.  Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication events.

Authors:  Vikas R Dharnidharka; Sushil Gupta; Eihab Al Khasawneh; Allah Haafiz; Jonathan J Shuster; Douglas W Theriaque; Amir H Shahlaee; Timothy J Garrett
Journal:  Pediatr Transplant       Date:  2011-02-24

Review 10.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.